Sinclair told Joe Rogan GLP-1 drugs could double the risk of sudden vision loss. Dr. Tatem says the figures Sinclair cited do come from real data.
Recap by typeshit. Post by @dralextatem on Instagram.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
14:36
A short look at the less discussed side effects of the experimental weight loss shot retatrutide, which is still in trials and not approved.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
A short clip of Rosie O'Donnell discussing the tirzepatide drug Mounjaro. Few details are given beyond the title.
Loading…